Literature DB >> 15488260

Is the type of remission after a major depressive episode an important risk factor to relapses in a 4-year follow up?

Luis Pintor1, Xavier Torres, Victor Navarro, Silvia Matrai, Cristobal Gastó.   

Abstract

BACKGROUND: Rates of relapse and predictive relapse factors were studied over more than 4 years in a sample of Spanish outpatients with DSM-III-R criteria for unipolar major depressive episode.
METHODS: A final sample of 139 outpatient was followed monthly in a naturalistic study. The Structured Clinical Interview for DSM-III-R was used. Phases of evolution were recorded using the Hamilton Depression Rating Scale, applying the Frank criteria. Survival analysis, Kaplan-Meier product limit and proportional hazards models were used.
RESULTS: A higher rate of relapses was observed in the partial remission group (91.4%) compared to the complete remission one (51.3%). The four factors with predictive relapse value were: "partial remission versus complete remission", "the intensity of clinical symptoms", "the age" and "the number of previous depressive episodes". The existence of partial remission was the most powerful predictive factor. LIMITATIONS: The decreasing sample size during the follow-up and the difficulty in warranting the treatment compliance.
CONCLUSIONS: At medium term, relapse rates for a major depressive episode are high. Partial remission after a depressive episode seems to be an important predictive factor for relapses in a 4-year follow-up. CLINICAL RELEVANCE: Not reaching complete remission is a strong risk factor for relapses in a 4-year follow up study.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15488260     DOI: 10.1016/j.jad.2003.11.008

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  23 in total

1.  Neuroplasticity and second messenger pathways in antidepressant efficacy: pharmacogenetic results from a prospective trial investigating treatment resistance.

Authors:  Chiara Fabbri; Concetta Crisafulli; Raffaella Calati; Diego Albani; Gianluigi Forloni; Marco Calabrò; Rosalba Martines; Siegfried Kasper; Joseph Zohar; Alzbeta Juven-Wetzler; Daniel Souery; Stuart Montgomery; Julien Mendlewicz; Alessandro Serretti
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-03-04       Impact factor: 5.270

2.  Which depressive symptoms remain after response to cognitive therapy of depression and predict relapse and recurrence?

Authors:  Daniel J Taylor; Heather M Walters; Jeffrey R Vittengl; Steven Krebaum; Robin B Jarrett
Journal:  J Affect Disord       Date:  2009-09-05       Impact factor: 4.839

3.  Predicting relapse with individual residual symptoms in major depressive disorder: a reanalysis of the STAR*D data.

Authors:  Hitoshi Sakurai; Takefumi Suzuki; Kimio Yoshimura; Masaru Mimura; Hiroyuki Uchida
Journal:  Psychopharmacology (Berl)       Date:  2017-05-03       Impact factor: 4.530

4.  Predicting relapse in major depressive disorder using patient-reported outcomes of depressive symptom severity, functioning, and quality of life in the Individual Burden of Illness Index for Depression (IBI-D).

Authors:  Waguih William Ishak; Jared M Greenberg; Robert M Cohen
Journal:  J Affect Disord       Date:  2013-06-19       Impact factor: 4.839

Review 5.  Evidence for the management of adolescent depression.

Authors:  R Eric Lewandowski; Mary C Acri; Kimberly E Hoagwood; Mark Olfson; Greg Clarke; William Gardner; Sarah Hudson Scholle; Sepheen Byron; Kelly Kelleher; Harold A Pincus; Samantha Frank; Sarah M Horwitz
Journal:  Pediatrics       Date:  2013-09-16       Impact factor: 7.124

6.  Faster remission of chronic depression with combined psychotherapy and medication than with each therapy alone.

Authors:  Rachel Manber; Helena C Kraemer; Bruce A Arnow; Madhukar H Trivedi; A John Rush; Michael E Thase; Barbara O Rothbaum; Daniel N Klein; James H Kocsis; Alan J Gelenberg; Martin E Keller
Journal:  J Consult Clin Psychol       Date:  2008-06

7.  Risk factors of recurrent sickness absence due to depression: a two-year cohort study among Japanese employees.

Authors:  M Endo; T Muto; Y Haruyama; M Yuhara; T Sairenchi; R Kato
Journal:  Int Arch Occup Environ Health       Date:  2014-03-19       Impact factor: 3.015

Review 8.  The impact of residual symptoms on outcome of major depression.

Authors:  Noel Kennedy; Kevin Foy
Journal:  Curr Psychiatry Rep       Date:  2005-12       Impact factor: 8.081

9.  Mindfulness-based cognitive therapy as a treatment for chronic depression: A preliminary study.

Authors:  Thorsten Barnhofer; Catherine Crane; Emily Hargus; Myanthi Amarasinghe; Rosie Winder; J Mark G Williams
Journal:  Behav Res Ther       Date:  2009-02-05

10.  Residual symptoms and functioning in depression, does the type of residual symptom matter? A post-hoc analysis.

Authors:  Irene Romera; Víctor Pérez; Antonio Ciudad; Luis Caballero; Miguel Roca; Pepa Polavieja; Inmaculada Gilaberte
Journal:  BMC Psychiatry       Date:  2013-02-11       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.